Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GUTS | Common Stock | Conversion of derivative security | +278K | 278K | Feb 6, 2024 | See footnote | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GUTS | Series F Preferred Stock | Conversion of derivative security | -596K | -100% | 0 | Feb 6, 2024 | Common Stock | 278K | See footnote | F1, F2 |
Id | Content |
---|---|
F1 | In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. |
F2 | Represents securities held by Population Health Capital Partners II, L.P. ("PHPII"). The Reporting Person is the Founder of Population Health Partners GP, LLC, the general partner of PHPII, and, as a result, may be deemed to share voting and investment power with respect to the shares held by PHPII. Dr. Meanwell disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |